{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:17Z","timestamp":1753891217489,"version":"3.41.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074497"],"award-info":[{"award-number":["82074497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M731031"],"award-info":[{"award-number":["2023M731031"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Optic atrophy (OA) is primarily caused by damage to the retinal pathway system, including widespread degeneration of retinal ganglion cells and axons, leading to visual impairment and blindness. Despite its clinical significance and diverse etiological factors, there is currently a lack of comprehensive bibliometric analyses exploring research trends and hotspots within this field.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>This study retrieved relevant literature on OA published between 2003 and 2023 from the Web of Science Core Collection database. We conducted a bibliometric analysis using tools such as CiteSpace, VOSviewer, and SCImago Graphica to examine annual publication trends, co-occurrence patterns, collaborative networks among countries and institutions, and the evolution of research hotspots of OA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 5,274 publications were included in the bibliometric analysis, comprising 4,561 research articles and 713 review articles. The United States emerged as the leading country in OA research, followed by Germany and China. Over the past two decades, the primary research hotspots focused on \u201cmitochondrial dysfunction,\u201d \u201chereditary optic neuropathy,\u201d \u201cocular hypertension\u201d and \u201cdiagnostic techniques.\u201d Future research trends are likely to revolve around \u201cmolecular mechanisms\u201d and \u201ctherapeutic targets.\u201d<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This bibliometric analysis provides an overview of research developments in OA over the past 20\u202fyears, highlighting the emphasis on the pathological basis of OA and advancements in diagnostic and therapeutic approaches. Future studies should continue to explore the molecular basis of mitochondrial dysfunction to identify potential gene therapy targets for treating OA.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1497446","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:59:36Z","timestamp":1736146776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A bibliometric analysis of optic atrophy from 2003 to 2023: research trends and hot spots"],"prefix":"10.3389","volume":"11","author":[{"given":"Liyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feixue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/ceo.12734","article-title":"Changing patterns in paediatric optic atrophy aetiology: 1979 to 2015","volume":"44","author":"Zheng","year":"2016","journal-title":"Clin Experiment Ophthalmol"},{"key":"ref2","first-page":"394","article-title":"Visual function in patients with optic nerve pallor (optic atrophy)","volume":"95","author":"DeWitt","year":"2003","journal-title":"J Natl Med Assoc"},{"volume-title":"Optic atrophy","year":"2023","author":"Ahmad","key":"ref3"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5144\/0256-4947.2017.232","article-title":"Etiology of optic atrophy: a prospective observational study from Saudi Arabia","volume":"37","author":"Mbekeani","year":"2017","journal-title":"Ann Saudi Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ncl.2010.03.005","article-title":"Nonglaucomatous optic atrophy","volume":"28","author":"Golnik","year":"2010","journal-title":"Neurol Clin"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/iovs.62.9.9","article-title":"Diabetes exacerbates the intraocular pressure-independent retinal ganglion cells degeneration in the DBA\/2J model of glaucoma","volume":"62","author":"Amato","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in glaucoma: from the back to the front of the eye, and beyond","volume":"83","author":"Baudouin","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"111124","DOI":"10.1016\/j.celrep.2022.111124","article-title":"Pathological mitophagy disrupts mitochondrial homeostasis in Leber\u2019s hereditary optic neuropathy","volume":"40","author":"Danese","year":"2022","journal-title":"Cell Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1600-0420.2005.00448.x","article-title":"Dominant optic atrophy: correlation between clinical and molecular genetic studies","volume":"83","author":"Puomila","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/aos.13285","article-title":"OPA1 analysis in an international series of probands with bilateral optic atrophy","volume":"95","author":"Liskova","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"824885","DOI":"10.3389\/fphar.2021.824885","article-title":"Caffeine protects against retinal inflammation","volume":"12","author":"Conti","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.2337\/db22-0515","article-title":"Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy","volume":"72","author":"Dionysopoulou","year":"2023","journal-title":"Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.3390\/molecules26154673","article-title":"Lipid nanoparticles traverse non-corneal path to reach the posterior eye segment: in vivo evidence","volume":"26","author":"Puglia","year":"","journal-title":"Molecules"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tree.2018.11.007","article-title":"Research weaving: visualizing the future of research synthesis","volume":"34","author":"Nakagawa","year":"2019","journal-title":"Trends Ecol Evol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"104608","DOI":"10.1016\/j.neubiorev.2022.104608","article-title":"Half a century of research on antipsychotics and schizophrenia: a scientometric study of hotspots, nodes, bursts, and trends","volume":"136","author":"Sabe","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1517\/14712598.2014.920813","article-title":"Emerging trends and new developments in regenerative medicine: a scientometric update (2000\u20132014)","volume":"14","author":"Chen","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"894006","DOI":"10.3389\/fneur.2022.894006","article-title":"Global trends and hotspots in trigeminal neuralgia research from 2001 to 2021: a bibliometric analysis","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.cell.2006.06.010","article-title":"Mitochondria: dynamic organelles in disease, aging, and development","volume":"125","author":"Chan","year":"2006","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nrm3013","article-title":"Mitochondrial fusion and fission in cell life and death","volume":"11","author":"Westermann","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"R551","DOI":"10.1016\/j.cub.2006.06.054","article-title":"Mitochondria: more than just a powerhouse","volume":"16","author":"McBride","year":"2006","journal-title":"Curr Biol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1074\/jbc.C200677200","article-title":"Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis","volume":"278","author":"Olichon","year":"2003","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3145\/epi.2022.sep.02","article-title":"SCImago Graphica: a new tool for exploring and visually communicating data","volume":"31","author":"Hassan-Montero","year":"2022","journal-title":"Inf Prof"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"ref26","first-page":"121","article-title":"Searching for clinical evidence in CiteSpace","volume":"2005","author":"Chen","year":"2005","journal-title":"AMIA Annu Symp Proc"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","article-title":"Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study","volume":"15","author":"Martinez-Lapiscina","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/diagnostics13020232","article-title":"OCT and OCT angiography update: clinical application to age-related macular degeneration, central serous chorioretinopathy, macular telangiectasia, and diabetic retinopathy","volume":"13","author":"Zhang","year":"2023","journal-title":"Diagnostics"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.eye.6702694","article-title":"Comparison of the GDx VCC scanning laser polarimeter and the stratus optical coherence tomograph in the detection of band atrophy of the optic nerve","volume":"22","author":"Monteiro","year":"2008","journal-title":"Eye"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbabio.2009.02.024","article-title":"Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders","volume":"1787","author":"Carelli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/13816819709057122","article-title":"Optic neuropathy associated with mitochondrial tRNA[Leu(UUR)] A3243G mutation","volume":"18","author":"Hwang","year":"1997","journal-title":"Ophthalmic Genet"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1086\/501236","article-title":"Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees","volume":"78","author":"Carelli","year":"2006","journal-title":"Am J Hum Genet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40123-022-00611-x","article-title":"Indirect comparison of lenadogene nolparvovec gene therapy versus natural history in patients with leber hereditary optic neuropathy carrying the m.11778G>A MT-ND4 mutation","volume":"12","author":"Carelli","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/B978-0-12-821751-1.00010-5","article-title":"Mitochondrial optic neuropathies","volume":"194","author":"Carelli","year":"2023","journal-title":"Handb Clin Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","article-title":"The APOSTEL recommendations for reporting quantitative optical coherence tomography studies","volume":"86","author":"Cruz-Herranz","year":"2016","journal-title":"Neurology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.cmet.2015.05.007","article-title":"The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage","volume":"21","author":"Varanita","year":"2015","journal-title":"Cell Metab"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08164622.2021.1947745","article-title":"Disorders of vision in multiple sclerosis","volume":"105","author":"Dhanapalaratnam","year":"2022","journal-title":"Clin Exp Optom"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.neubiorev.2020.09.011","article-title":"Function of WFS1 and WFS2 in the central nervous system: implications for Wolfram syndrome and Alzheimer\u2019s disease","volume":"118","author":"Li","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.3390\/ijms24086977","article-title":"Optic neuropathies: current and future strategies for optic nerve protection and repair","volume":"24","author":"Miller","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1177\/08830738050200051801","article-title":"Progressive encephalopathy with edema, hypsarrhythmia, and optic nerve atrophy (PEHO)-like syndrome: what diagnostic characteristics are defining?","volume":"20","author":"D'Arrigo","year":"2005","journal-title":"J Child Neurol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/genes12020147","article-title":"From transcriptomics to treatment in inherited optic neuropathies","volume":"12","author":"Gilhooley","year":"2021","journal-title":"Genes"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/cells12010171","article-title":"The past and present lives of the intraocular transmembrane protein CD36","volume":"12","author":"Yang","year":"2022","journal-title":"Cells"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1038\/cddis.2011.117","article-title":"A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics","volume":"2","author":"Nguyen","year":"2011","journal-title":"Cell Death Dis"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/14712598.2018.1389886","article-title":"Gene therapy for inherited retinal and optic nerve degenerations","volume":"18","author":"Moore","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/medicina60071064","article-title":"Wolfram syndrome type I case report and review-focus on early diagnosis and genetic variants","volume":"60","author":"Jurca","year":"2024","journal-title":"Medicina"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1358\/dot.2022.58.11.3448291","article-title":"Current treatment options for treating OPA1-mutant dominant optic atrophy","volume":"58","author":"Ferro Desideri","year":"2022","journal-title":"Drugs Today"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1497446\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:59:39Z","timestamp":1736146779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1497446\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":50,"alternative-id":["10.3389\/fmed.2024.1497446"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1497446","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"article-number":"1497446"}}